What is the common examiner trap about Science & Tech in UPSC exams?

They may ask about the 'first successful human cell line' and give options like 'HeLa', 'HEK 293', or 'CHO cells'. HeLa is the correct answer. Another trap is linking the year to a different medical discovery (e.g., DNA structure in 1953).

What should UPSC aspirants remember about Science & Tech for Prelims?

1. Target this Data: 1951 (Year of HeLa cell extraction) 2. Target this Nodal Body: Johns Hopkins Centre (Institution involved) 3. Target this Legal Point: Informed Consent (Core ethical principle violated)

Science & TechnologyEthics

Take AI Challenge ▸

News 2 of 22

HeLa Cell Line Bioethics: Landmark 2026 Settlement for Henrietta Lacks' Family Sets New Informed Consent Regulations

Q: The HeLa cell line, central to the debate on medical ethics, was derived from a patient treated at which renowned medical institution?

Johns Hopkins Centre, As per the article, Henrietta Lacks sought treatment at the 'coloured ward' in Johns Hopkins Centre in 1951, where her cells were extracted without consent to create the HeLa line.

Q: Consider the following statements regarding the HeLa cell line case: 1. The cells were extracted from Henrietta Lacks in 1951 without her informed consent. 2. The HeLa cell line was the first animal cell line to be successfully cultured indefinitely. 3. A landmark settlement acknowledging the harm done to the Lacks family was reached in the year 2026. Which of the statements given above is/are correct?

Both 1 and 3, Statement 1 is correct as the article clearly states cells were extracted without permission in 1951. Statement 2 is incorrect; HeLa was the first HUMAN cell line, not animal cell line. Statement 3 is correct as the article mentions the family found closure with a settlement in 2026.

Q: In which year was the book 'The Immortal Life of Henrietta Lacks' by Rebecca Skloot, which brought global attention to this bioethics case, published?

2010, The article explicitly states that the best-selling book 'The Immortal Life of Henrietta Lacks' by Rebecca Skloot was published in 2010. This book played a crucial role in highlighting the ethical issues.

Q: What is the primary ethical principle that the case of Henrietta Lacks and the HeLa cell line most directly violated, leading to modern reforms?

Informed Consent, The core ethical violation in this case was the lack of informed consent, as cells were taken from Henrietta Lacks without her knowledge or permission. The article states this omission led to a battle for dignity and today, more regulations govern ethical research based on informed consent.

Science & Tech Polity Social IssuesCORE

Target:UPSC GS-IIIMPSCTeachingSSC GAPrelims HighMains HighStatic GK Link

17 May 2026

~2 min

Source: The Hindu

Key Data:195131 years2010202675 years

Bodies:Johns Hopkins Centre

Practice MCQs from today's news ▸

~2 min · Quick mode

What This Article Covers

1.The immortal HeLa cell line, vital for virology, vaccines, and cancer research, was taken from Henrietta Lacks in 1951 without her knowledge or consent.

2.After decades of exploitation, her family secured a landmark settlement in 2026, leading to financial compensation and new ethical regulations emphasizing informed consent.

3.This case is a cornerstone for questions on medical ethics, patient rights, and the historical exploitation of marginalized communities in scientific advancement.

The Big Picture

Prelims · HighMains · High

The story of the HeLa cell line, derived from Henrietta Lacks without consent in 1951, is a landmark case in bioethics. After a 75-year struggle, a 2026 settlement with Johns Hopkins acknowledges the harm and establishes new ethical norms for patient rights and informed consent in biomedical research, making it crucial for GS-IV (Ethics) and Science & Tech.

Exam Lens

Quick Exam Facts From News

HeLa Cell Year1951

PatientHenrietta Lacks (African American)

Age at Death31 years

Key InstitutionJohns Hopkins Centre

BookThe Immortal Life of Henrietta Lacks (2010)

Settlement Year2026

1-Minute Revision

›HeLa Cell Year: 1951
›Patient: Henrietta Lacks (African American)
›Target this Data: 1951 (Year of HeLa cell extraction)
›Target this Nodal Body: Johns Hopkins Centre (Institution involved)
›Target this Legal Point: Informed Consent (Core ethical principle violated)

Mastered this topic? Test your knowledge with a full MCQ quiz.

Practice exam-style questions, track your score, and strengthen your recall.

News Snapshot

🧬

Immortal Cell Line

HeLa, the first human cells to survive and multiply indefinitely outside the body, were taken from Henrietta Lacks' cervical tumor without her consent in 1951.

⚖️

Landmark Ethical Settlement

In 2026, after a 75-year fight, the Lacks family secured a landmark settlement with Johns Hopkins, acknowledging harm and setting new ethical standards for research.

📚

Bioethics Milestone

The case, highlighted in Rebecca Skloot's 2010 book, forced a global reckoning on informed consent, patient dignity, and reparative justice in science.

Detailed Analysis & Strategic Depth

Context / Background

In the 1950s, bioethical norms, especially informed consent, were weak or non-existent, particularly for marginalized groups. Henrietta Lacks, an African American woman treated in a segregated 'coloured ward' at Johns Hopkins in 1951, had her cancer cells taken without permission. These 'HeLa' cells became the first immortal human cell line, revolutionizing biomedical research while her identity and contribution were erased for decades.

Core Analysis & Implications

The case exposes 'epistemic dominance' where powerful institutions exploited vulnerable individuals. While HeLa cells underpinned breakthroughs in polio vaccines, cancer research, and genetics, the Lacks family remained impoverished and unaware. The 2026 settlement is not just about compensation; it reinforces the supremacy of informed consent, mandates patient/community involvement in research, and sets a precedent for reparative justice for historical exploitation in science.

Future Outlook / Way Forward

This landmark agreement is expected to refine global research ethics policies. It strengthens calls for transparent crediting of biological material donors and mechanisms to prevent such violations. The story serves as a permanent cautionary tale, ensuring that scientific progress is aligned with respect for human dignity and equitable benefit-sharing, influencing ethics curricula and institutional review boards worldwide.

Key Facts at a Glance

HeLa Cell Year1951

PatientHenrietta Lacks (African American)

Age at Death31 years

Key InstitutionJohns Hopkins Centre

BookThe Immortal Life of Henrietta Lacks (2010)

Settlement Year2026

You've read the full analysis. Now test your understanding.

Practice exam-style questions based on this article.

Q1Static LinkageEasyUPSC, SSC

The HeLa cell line, central to the debate on medical ethics, was derived from a patient treated at which renowned medical institution?

Q2Statement-basedMediumUPSC

Consider the following statements regarding the HeLa cell line case:

1. The cells were extracted from Henrietta Lacks in 1951 without her informed consent.

2. The HeLa cell line was the first animal cell line to be successfully cultured indefinitely.

3. A landmark settlement acknowledging the harm done to the Lacks family was reached in the year 2026.

Which of the statements given above is/are correct?

Q3Data-centricMediumUPSC, SSC

In which year was the book 'The Immortal Life of Henrietta Lacks' by Rebecca Skloot, which brought global attention to this bioethics case, published?

Q4Application/ImpactEasyUPSC, SSC

What is the primary ethical principle that the case of Henrietta Lacks and the HeLa cell line most directly violated, leading to modern reforms?

All 20 MCQs ▸

Read original article from The Hindu

You finished this topic

Practice 3 MCQs from this news Next Article

Explore Related Topics

Science & TechView Topic MCQs →PolityView Topic MCQs →Social IssuesView Topic MCQs →

PreviousTata Electronics, ASML to Build India's 1st Front-end Fab in Dholera, Gujarat with $11 Billion Investment Next Make in India Defence Sector: Import Dependency, Strategic Partnership Model, FDI Liberalization, and Lessons from Global Conflicts

Related Current Affairs

Polity Current Affairs

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

Science & Tech Current Affairs

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

Social Issues Current Affairs

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

Science & Tech Current Affairs

IARC Classifies Three WHO Essential Medicines as Group 1 Carcinogens: Hydrochlorothiazide, Voriconazole, Tacrolimus

IARC, the WHO cancer research agency, has classified three widely used drugs—hydrochlorothiazide, voriconazole, and tacrolimus—as Group 1 carcinogens. Despite this, experts stress that patients should not stop treatment as the benefits for hypertension, fungal infections, and organ transplant rejection far outweigh the cancer risk. The drugs are on the WHO Model List of Essential Medicines and are commonly prescribed in India.

Science & Tech Current Affairs

IISc SraVaani: India's First Open-Source Speech Recognition Model for 65 Languages

IISc's SPIRE Lab, in collaboration with ARTPARK and Google, has released SraVaani – the first multilingual Indian speech recognition model trained on 65 languages and dialects. It extends ASR to 45 underserved regional languages, potentially benefiting 25 crore people. This marks a major step in inclusive AI for India's linguistic diversity.

Social Issues Current Affairs

Meta Trial: $567 Mn Penalty for Child Addiction, 29-State Probe on Social Media Design

A US trial against Meta over addictive social media design for children could reshape Big Tech accountability. With penalties of $567 million and a $6 million jury verdict, this case highlights the growing scrutiny of platform design and its impact on youth mental health, a key issue for GS2 (Social Justice) and GS3 (Technology).

Science & Tech Current Affairs

Merck-Moderna mRNA Drug Intismeran Autogene Cuts Melanoma Recurrence in Phase 3 Trial with 1,137 Patients

For the first time, an mRNA-based personalized cancer vaccine (intismeran autogene) developed by Merck and Moderna has proven effective in reducing melanoma recurrence in a large late-stage trial with 1,137 patients. This marks a breakthrough in cancer immunotherapy, demonstrating that mRNA technology, previously successful against COVID-19, can be adapted to fight cancer.

Science & Tech Current Affairs

India's AI Pipeline: 43% Women STEM Graduates, Only 10% in Leadership – Need for Inclusive AI

India's AI ambition faces a hidden gender crisis: women drop from 43% of STEM graduates to just 10% of senior AI leadership. This pipeline leakage, driven by social barriers and digital divide, risks automating existing inequalities. For exam aspirants, this article provides critical data on gender disparity in tech and the imperative for inclusive AI development.

Start Today's Quiz(20 Qs)

Take Today's Quiz

20 Qs • 5-7 Mins

HeLa Cell Line Bioethics: Landmark 2026 Settlement for Henrietta Lacks' Family Sets New Informed Consent Regulations

Exam Lens

Quick Exam Facts From News

1-Minute Revision

News Snapshot

Immortal Cell Line

Landmark Ethical Settlement

Bioethics Milestone

Detailed Analysis & Strategic Depth

Context / Background

Core Analysis & Implications

Future Outlook / Way Forward

Prelims Flashpoints

Key Facts at a Glance